
Leonardo Martinez, PhD, MPH
Assistant Professor, Epidemiology - Boston University School of Public Health
Biography
Leo Martinez joined the Department of Epidemiology at Boston University in 2021.
Dr. Martinez uses epidemiological and quantitative approaches to study early-life risk factors for pediatric tuberculosis in high-burden settings, tuberculosis transmission dynamics in high-risk populations (e.g., prisoners, persons living with HIV or diabetes), and the relationship between tuberculosis and non-communicable diseases.
Dr. Martinez's lab is currently working with colleagues and collaborators in several countries globally. We believe that collaboration across professional disciplines, backgrounds, and perspectives is the key to solving intractable health issues and the lab welcomes discussions with others working on these same health issues.
Classes Taught
- SPHEP764
- SPHEP770
- SPHEP784
Publications
- Published on 6/13/2025
Horsburgh CR, E Jenkins H, Martinez L, White LF. Data-driven targets for reducing the global burden of TB. IJTLD Open. 2025 Jun; 2(6):352-358. PMID: 40530384.
Read At: PubMed
- Published on 5/30/2025
Cobelens F, Pelzer PT, Churchyard GJ, Garcia-Basteiro A, Hatherill M, Hill PC, Martinez L, White RG. Sample size efficiency of restricting participation in tuberculosis vaccine trials to interferon-gamma release assay-positive participants. Vaccine. 2025 May 30; 61:127301. PMID: 40450848.
Read At: PubMed
- Published on 4/9/2025
Venkatesan N, Faust L, Lobo R, Enkh-Amgalan H, Kunor T, Sifumba Z, Rane S, O'Brien K, Kumar B, Maimbolwa CN, Mayta M, Patel H, Huong LM, Heitkamp P, Huddart S, Romanowski K, Hiebert M, Zimmer AJ, MacLean EL, Caceres-Cardenas G, Villa Castillo L, Black J, Batchu M, Tschampl CA, Rea E, Campbell T, Heffernan C, Long R, Raithby L, Daftary A, Chorna Y, Zheng A, Martinez L, Kulkarni S, Denkinger CM, Castro MDM, Sulis G, Furin J, McKenna L, Frick M, Nathavitharana RR, Oga-Omenka C, Ananthakrishnan R, Malar J, Ugarte-Gil C, Vandevelde W, Kerkhoff AD, Winarni P, Fox G, Nguyen TA, Teo AKJ, Yapa HM, Pham NY, Ratnasingham A, Bernays S, Trinh HD, Khan U, Alvarez GG, Deluca A, Nash M, Rucsineanu O, Vasiliu A, Stillo J, Nahid P, Pai M, Johnston J, Harries AD, Golub JE. Fighting tuberculosis hand in hand: A call to engage communities affected by TB as essential partners in research. PLOS Glob Public Health. 2025; 5(4):e0004437. PMID: 40202965.
Read At: PubMed
- Published on 4/1/2025
Zheng A, Faust L, Harries AD, Avedillo P, Akodu M, Galvan M, Barreto-Duarte B, Andrade BB, Ugarte-Gil C, Garcia-Basteiro AL, Espinal M, Warren JL, Martinez L. Changes in incarceration and tuberculosis notifications from prisons during the COVID-19 pandemic in Europe and the Americas: a time-series analysis of national surveillance data. Lancet Public Health. 2025 Apr; 10(4):e285-e294. PMID: 40175010.
Read At: PubMed
- Published on 4/1/2025
Zhang S, Xu Z, Wang Z, Fei X, Li Z, Zhu L, Martinez L, Wang J, Liu Q. Changes in gut microbiome following anti-tuberculosis treatment: a prospective cohort from eastern China. BMC Infect Dis. 2025 Apr 01; 25(1):453. PMID: 40169991.
Read At: PubMed
- Published on 3/24/2025
Ehrlich J, Suñer C, Churchyard G, Cobelens F, Hatherill M, Mendelsohn SC, Nelson KN, Scriba T, Theron G, Martinez L, Garcia-Basteiro AL. Unveiling a hidden phenotype of early tuberculosis. Lancet Respir Med. 2025 May; 13(5):385-387. PMID: 40147469.
Read At: PubMed
- Published on 2/27/2025
Jaswal MR, Martinez L, Brooks M, Farooq S, Safdar N, Shah JA, Islam Z, Nasir K, Fareed U, Manzar S, Maniar R, Siddiqui S, Khowaja S, Khan AJ, Hussain H, Malik AA. Tuberculosis preventive treatment for household contacts at health facility and community settings in Pakistan. Clin Infect Dis. 2025 Feb 27. PMID: 40036384.
Read At: PubMed
- Published on 2/25/2025
Lu P, Martinez L, Xue H, Liu Q, Ding X, Pan J, Ding H, Lu W, Zhu L, Wang J. Comparative evaluation of QuantiFERON-TB gold in-tube plus for Mycobacterium tuberculosis infection among adolescents in China. BMC Public Health. 2025 Feb 25; 25(1):778. PMID: 40001083.
Read At: PubMed
- Published on 2/16/2025
Wang J, Yu L, Yang Z, Shen P, Sun Y, Shui L, Tang M, Jin M, Chen B, Ge Y, Lin H, Shen Y, Chen K, Martinez L. Development of chronic obstructive pulmonary disease after a tuberculosis episode in a large, population-based cohort from Eastern China. Int J Epidemiol. 2025 Feb 16; 54(2). PMID: 39993264.
Read At: PubMed
- Published on 2/3/2025
Chen C, Xue H, Horsburgh CR, Amour M, Hatherill M, Tameris M, von Reyn CF, Rees C, Shen Y, McShane H, García-Basteiro AL, Liu D, Wang Y, Nathavitharana RR, Graviss EA, Shao Y, Liu Q, Lu W, Zhu L, Martinez L. Trajectories of Interferon-Gamma Release Assay Results Over 2 Years in Independent Cohorts From China, South Africa, Tanzania, and the United States. Chest. 2025 Feb 03. PMID: 39909102.
Read At: PubMed
View 130 more publications:View Full Profile at BUMC
News & In the Media
-
Published on March 31, 2025
Many TB Cases May Have Gone Undetected in Prisons in Europe and the Americas During COVID-19
- Published on March 14, 2025
-
Published on November 8, 2024
10% of Children in High-Burden Tuberculosis Settings May Develop the Disease by Age 10
-
Published on May 13, 2024
Risk-Targeted Preventive TB Treatment Works, Particularly with Infection Testing
- Published on May 9, 2024
-
Published on July 14, 2023
Tuberculosis in Prisons Goes Undetected at Alarming Rates, Global Data Show
-
Published on July 11, 2023
Thousands of IIOJK Detainees Could Suffer as Prisoners in India at 5 Times More TB Risk: Study
- Published on July 6, 2023
- Published on July 1, 2023
-
Published on June 29, 2023
Nearly Half of Tuberculosis Cases in Prisons Worldwide Go Undetected
-
Published on April 14, 2023
Pediatric TB May Affect Lung Functioning, Growth Later in Life
-
Published on August 12, 2022
BCG Vaccine Prevents TB in Young Children, but Not Adults – New Study
-
Published on August 9, 2022
BCG Vaccine Prevents Tuberculosis in Young Children, but Not Adults
- Published on January 19, 2022
-
Published on January 19, 2022
Expect More Worrisome Variants after Omicron, Scientists Say
-
Published on January 3, 2022
CDC Study Says Omicron Variant’s Incubation Period Is about 3 Days—Here’s What That Means
-
Published on November 18, 2021
Children with Cytomegalovirus Infection by Age One More Likely to Develop Tuberculosis in Childhood
-
Published on November 17, 2021
Children with Cytomegalovirus Infection by Age 1 More Likely to Develop Tuberculosis in Childhood
- Published on August 30, 2021
- Published on August 30, 2021
-
Published on August 23, 2021
COVID-19 Is Most Transmissible 2 Days Before, 3 Days After Symptoms Appear
- Published on April 9, 2021